Corrigendum to: Peroxisome proliferator-activated receptor gamma (PPARγ) is central to the initiation and propagation of human angiomyolipoma, suggesting its potential as a therapeutic target (EMBO Mol Med, (2017), 9, (508-530), 10.15252/emmm.201506111)